 In 2008, the reported sales level for Tilcotil (tenoxicam) was 70 million SEK (approximately $10.5 million USD).The first members of the oxicam family of NSAIDs were brought to market in France in 1982.Shortly thereafter, tenoxicam went to phase III clinical trials for approval as use as an analgesic began in the 1980s.